Open Access 01-12-2020 | Acute Respiratory Distress-Syndrome | Research Letter
Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study
Published in: Critical Care | Issue 1/2020
Login to get access